These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 13704784)

  • 41. [Myxedema secondary to edematous scleroderma, treated with cortisone].
    BUREAU Y; JARRY ; BARRIERE
    Bull Soc Fr Dermatol Syphiligr; 1957; 64(1):104-5. PubMed ID: 13437038
    [No Abstract]   [Full Text] [Related]  

  • 42. High-dose dexamethasone in scleromyxedema: report of 2 additional cases.
    Kreuter A; Altmeyer P
    J Am Acad Dermatol; 2005 Oct; 53(4):739-40. PubMed ID: 16198811
    [No Abstract]   [Full Text] [Related]  

  • 43. [On a case of scleromyxedema].
    SCHUMACHERS-BRENDLER R
    Hautarzt; 1960 Aug; 11():368-70. PubMed ID: 13748967
    [No Abstract]   [Full Text] [Related]  

  • 44. [Scleromyxedema].
    Horio T; Yonezawa I
    Hifuka Kiyo; 1969 Feb; 64(1):15-23. PubMed ID: 5817878
    [No Abstract]   [Full Text] [Related]  

  • 45. [Scleromyxedema; a strange manifestation of myxothesaurodermy].
    GOTTRON HA
    Arch Klin Exp Dermatol; 1954; 199(1):71-91. PubMed ID: 13229312
    [No Abstract]   [Full Text] [Related]  

  • 46. Electron beam therapy in Arndt-Gottron's scleromyxoedema.
    Kavanagh GM; Matheson LM; Thwaites DJ; Hunter JA
    Br J Dermatol; 1997 Jul; 137(1):152-4. PubMed ID: 9274649
    [No Abstract]   [Full Text] [Related]  

  • 47. Scleroderma-like disorders.
    Foti R; Leonardi R; Rondinone R; Di Gangi M; Leonetti C; Canova M; Doria A
    Autoimmun Rev; 2008 Feb; 7(4):331-9. PubMed ID: 18295739
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Successful treatment of scleromyxoedema with high dose intravenous immunoglobulin.
    Karim A; Lawlor F; Black MM
    Clin Exp Dermatol; 2004 May; 29(3):317-8. PubMed ID: 15115524
    [No Abstract]   [Full Text] [Related]  

  • 49. Successful treatment of scleromyxedema with autologous peripheral blood stem cell transplantation.
    Lacy MQ; Hogan WJ; Gertz MA; Dispenzieri A; Rajkumar SV; Hayman S; Kumar S; Litzow MR; Schroeter AL
    Arch Dermatol; 2005 Oct; 141(10):1277-82. PubMed ID: 16230566
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Use of IGIV in the treatment of atopic dermatitis, urticaria, scleromyxedema, pyoderma gangrenosum, psoriasis, and pretibial myxedema.
    Jolles S; Hughes J
    Int Immunopharmacol; 2006 Apr; 6(4):579-91. PubMed ID: 16504920
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tumorous variant of scleromyxedema. Successful therapy with intravenous immunoglobulins.
    Wojas-Pelc A; Błaszczyk M; Glińska M; Jabłońska S
    J Eur Acad Dermatol Venereol; 2005 Jul; 19(4):462-5. PubMed ID: 15987294
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Nephrogenic systemic fibrosis: a histopathological study of eight cases of a recently described entity.
    Digby S; Macduff E; Blessing K; Holmes S
    Histopathology; 2008 Mar; 52(4):531-4. PubMed ID: 18315613
    [No Abstract]   [Full Text] [Related]  

  • 53. Thalidomide as a potential treatment for scleromyxedema.
    Caradonna S; Jacobe H
    Arch Dermatol; 2004 Mar; 140(3):277-80. PubMed ID: 15023770
    [No Abstract]   [Full Text] [Related]  

  • 54. Histopathologic comparison of nephrogenic fibrosing dermopathy and scleromyxedema.
    Kucher C; Xu X; Pasha T; Elenitsas R
    J Cutan Pathol; 2005 Aug; 32(7):484-90. PubMed ID: 16008692
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Localized scleroderma and systemic sclerosis: is there a connection?
    Gupta RA; Fiorentino D
    Best Pract Res Clin Rheumatol; 2007 Dec; 21(6):1025-36. PubMed ID: 18068859
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evaluation of heart rhythm variability and arrhythmia in children with systemic and localized scleroderma.
    Wozniak J; Dabrowski R; Luczak D; Kwiatkowska M; Musiej-Nowakowska E; Kowalik I; Szwed H
    J Rheumatol; 2009 Jan; 36(1):191-6. PubMed ID: 19040309
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Scleromyxedema-like lesions of patients in renal failure contain hyaluronan: a possible pathophysiological mechanism.
    Neudecker BA; Stern R; Mark LA; Steinberg S
    J Cutan Pathol; 2005 Oct; 32(9):612-5. PubMed ID: 16176298
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Lichen myxedematosus (papular mucinosis): new concepts and perspectives for an old disease.
    Rongioletti F
    Semin Cutan Med Surg; 2006 Jun; 25(2):100-4. PubMed ID: 16908401
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Microstomia as a complication of scleroderma].
    Phoa KH; de Baat P; de Baat C
    Ned Tijdschr Tandheelkd; 2003 Nov; 110(11):457-9. PubMed ID: 14669488
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Predictors of the scleroderma phenotype in fibroblasts from systemic sclerosis patients.
    Qi Q; Guo Q; Tan G; Mao Y; Tang H; Zhou C; Zeng F
    J Eur Acad Dermatol Venereol; 2009 Feb; 23(2):160-8. PubMed ID: 19054252
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.